Are insiders buying LXRX stock?

Yes — 3 distinct insiders have bought LXRX (LEXICON PHARMACEUTICALS, INC.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Feb 27, 2026.

How much LXRX stock have insiders bought?

Insiders have bought a combined $2.6M of LXRX across 6 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in LXRX?

A cluster buy is two or more distinct LEXICON PHARMACEUTICALS, INC. insiders — officers, directors, or 10% owners — each buying LXRX on the open market within a rolling window. LXRX has 1 detected cluster buy to date.

Where does this LXRX insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

LXRX insider buying

1 cluster buy

LEXICON PHARMACEUTICALS, INC. · Healthcare

When two or more insiders at LEXICON PHARMACEUTICALS, INC. buy LXRX on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in LXRX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$2.6M

Market cap

$1.0B

Detected clusters

Feb 2 – Feb 23, 2026
Detected Feb 23, 2026
2 insiders
Total bought
$2.6M
Market cap
$1.0B

All notable open-market buys in LXRX

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Feb 25, 2026	DEBBANE RAYMOND Director	2,000	$1.49	$3.0K	SEC ↗
Feb 23, 2026	DEBBANE RAYMONDcluster Director	100,000	$1.47	$147.0K	SEC ↗
Feb 20, 2026	DEBBANE RAYMONDcluster Director	100,000	$1.48	$148.0K	SEC ↗
Feb 18, 2026	DEBBANE RAYMONDcluster Director	133,688	$1.32	$176.5K	SEC ↗
Feb 17, 2026	DEBBANE RAYMONDcluster Director	76,857	$1.31	$100.7K	SEC ↗
Feb 2, 2026	Artal Group S.A.cluster Director, 10% Owner	1,538,462	$1.30	$2.0M	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

LXRX insider buying — FAQ

Are insiders buying LXRX stock?: Yes — 3 distinct insiders have bought LXRX (LEXICON PHARMACEUTICALS, INC.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Feb 27, 2026.
How much LXRX stock have insiders bought?: Insiders have bought a combined $2.6M of LXRX across 6 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in LXRX?: A cluster buy is two or more distinct LEXICON PHARMACEUTICALS, INC. insiders — officers, directors, or 10% owners — each buying LXRX on the open market within a rolling window. LXRX has 1 detected cluster buy to date.
Where does this LXRX insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in LXRX

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy LXRX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding LXRX.